Profile
Michael S.
Rosol's former jobs include Chief Executive Officer at Atherion Bioresearch, Inc., Senior Director-Business Development at Elucid Bioimaging, Inc. in 2016, Associate Director-Clinical & Translational at Novartis Institutes for Biomedical Research, Inc. from 2016 to 2018, Chief Medical Officer & Senior Vice President at Navidea Biopharmaceuticals, Inc. from 2018 to 2023, Head-Translational Imaging Group at Novartis Pharmaceuticals Corp.
from 2012 to 2015, Chief Scientific Officer at Medilumine, Inc. from 2015 to 2016, and Chief Development Officer at Plus Therapeutics, Inc. from 2025 to 2026.
Education includes a doctorate from Boston University School of Medicine.
Former positions of Michael Rosol
| Companies | Position | End |
|---|---|---|
| CERENOME, INC. | Corporate Officer/Principal | 20/04/2026 |
| NAVIDEA BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 30/03/2023 |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Corporate Officer/Principal | 01/12/2018 |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Corporate Officer/Principal | 01/11/2016 |
Medilumine, Inc. | Corporate Officer/Principal | 01/05/2016 |
Training of Michael Rosol
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes precision diagnostics and radiopharmaceutical agents | Health Technology |
Elucid Bioimaging, Inc.
Elucid Bioimaging, Inc. Packaged SoftwareTechnology Services Operates as an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient | Technology Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Plus Therapeutics, Inc.
Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medilumine, Inc. |
- Stock Market
- Insiders
- Michael Rosol
















